Cassava Sciences reported $0 in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Amgen USD 57.32B 2.72B Mar/2026
Biogen USD 8.09B 1.53B Jun/2026
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 186.08B 50.58B Mar/2026
Eli Lilly USD 43.37B 867M Mar/2026
Geron USD 122.07M 74K Mar/2026
J&J USD 54.99B 7.05B Mar/2026
Merck USD 49.12B 222M Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Novavax USD 233.31M 4.23M Sep/2024
Pfizer USD 63.19B 536M Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025